NovaGo Therapeutics
Series BSchlieren, SwitzerlandSep 2026
NovaGo Therapeutics raised €26M in a Series B round in Sep 2026. The company is based in Schlieren, Switzerland. Investors in the round: Neurimmune Holding, new investors, Pureos Ventures and 2 others. Data as of 4 Nov 2026.
Amount raised
€26M
€25,911,211
Native amount
30,000,000 USD
Stage
Series B
series b
Investors
5
Provenance & confidence
High confidenceAmount
30,000,000 USD
ECB-at-date → €26M · rate 1.1578 on 2026-09-02
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Sep 2026
Round type
series b
Amount (EUR)
€26M